Gravol and Oesophagitis aggravated - a phase IV clinical study of FDA data


Oesophagitis aggravated is found among people who take Gravol, especially for people who are male, 50-59 old, have been taking the drug for < 1 month.

The phase IV clinical study analyzes which people take Gravol and have Oesophagitis aggravated. It is created by eHealthMe based on reports of 5,332 people who have side effects when taking Gravol from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Mar, 22, 2023

5,332 people reported to have side effects when taking Gravol.
Among them, 9 people (0.17%) have Oesophagitis aggravated.

What is Gravol?

Gravol has active ingredients of dimenhydrinate. It is often used in nausea. eHealthMe is studying from 5,715 Gravol users for its effectiveness, alternative drugs and more.

What is Oesophagitis aggravated?

Oesophagitis aggravated (worse inflammation of oesophagus) is found to be associated with 1,113 drugs and 305 conditions by eHealthMe.

Number of Gravol and Oesophagitis aggravated reports submitted per year:

Could Gravol cause Oesophagitis aggravated?

Time on Gravol when people have Oesophagitis aggravated *:

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Oesophagitis aggravated when taking Gravol *:

  • female: 44.44 %
  • male: 55.56 %

Age of people who have Oesophagitis aggravated when taking Gravol *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 14.29 %
  • 30-39: 14.29 %
  • 40-49: 14.29 %
  • 50-59: 57.14 %
  • 60+: 0.0 %

Common drugs people take besides Gravol *:

  1. Benadryl: 4 people, 44.44%
  2. Lyrica: 4 people, 44.44%
  3. Vitamin D: 2 people, 22.22%
  4. Lemtrada: 2 people, 22.22%
  5. Celexa: 2 people, 22.22%
  6. Fentanyl: 2 people, 22.22%
  7. Percocet: 2 people, 22.22%
  8. Nexium: 2 people, 22.22%
  9. Zofran: 1 person, 11.11%
  10. Dexamethasone: 1 person, 11.11%

Common side effects people have besides Oesophagitis aggravated *:

  1. White Blood Cell Count Decreased: 4 people, 44.44%
  2. Breathing Difficulty: 4 people, 44.44%
  3. Memory Loss: 4 people, 44.44%
  4. Fatigue (feeling of tiredness): 4 people, 44.44%
  5. Hypoaesthesia Oral (reduced sense of touch or sensation in mouth): 4 people, 44.44%
  6. Muscle Aches (muscle pain): 4 people, 44.44%
  7. Oral Herpes (viral infection of mouth): 4 people, 44.44%
  8. Oropharyngeal Pain: 4 people, 44.44%
  9. Headache (pain in head): 4 people, 44.44%
  10. Hot Flush (sudden feelings of heat): 4 people, 44.44%

Common conditions people have *:

  1. Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 4 people, 44.44%
  2. Infection: 2 people, 22.22%
  3. Non-Small Cell Lung Cancer Stage Iii: 1 person, 11.11%
  4. Intervertebral Disc Protrusion (spinal disc protrusion): 1 person, 11.11%
  5. Crohn's Disease (condition that causes inflammation of the gastrointestinal tract): 1 person, 11.11%
  6. Blood Folate Decreased: 1 person, 11.11%
  7. Birth Control: 1 person, 11.11%

* Approximation only. Some reports may have incomplete information.

Do you take Gravol and have Oesophagitis aggravated?

Check whether Oesophagitis aggravated is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Oesophagitis aggravated and when was it recovered:

Expand to all the drugs that have ingredients of dimenhydrinate:

Alternative drugs to, pros and cons of Gravol:

Common Gravol side effects:

Browse all side effects of Gravol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Oesophagitis aggravated treatments and more:

COVID vaccines that are related to Oesophagitis aggravated:

Common drugs associated with Oesophagitis aggravated:

All the drugs that are associated with Oesophagitis aggravated:

Common conditions associated with Oesophagitis aggravated:

All the conditions that are associated with Oesophagitis aggravated:

How the study uses the data?

The study uses data from the FDA. It is based on dimenhydrinate (the active ingredients of Gravol) and Gravol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: